Alzheimer’s disease: Pathogenesis and prevention

Tau lesions (pretangles, neuropil threads, neurofibrillary tangles) in select neuronal types are essential to the pathogenesis of Alzheimer's disease. Pretangle formation marks the beginning of the pathological process and is of particular interest because it is temporally closer to the prevailing conditions that induce the pathological process underlying Alzheimer's disease in contrast to late‐stage disease. However, not all pretangles convert into neurofibrillary tangles. We propose that the development of tau lesions in Alzheimer's disease is traceable to differences between early‐ versus late‐maturing oligodendrocytes and to the exceptionally protracted myelination of late‐developing portions of the human brain. Conclusions drawn from these considerations should encourage development of new preventative and disease‐modifying strategies.

[1]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[2]  M. Mesulam,et al.  Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease , 2007, Neurobiology of Aging.

[3]  Jeff Kuret,et al.  Research towards tau imaging. , 2011, Journal of Alzheimer's disease : JAD.

[4]  I. Grundke‐Iqbal,et al.  Mechanisms of tau-induced neurodegeneration , 2009, Acta Neuropathologica.

[5]  L. Grinberg,et al.  The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? , 2009, Neuropathology and applied neurobiology.

[6]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[7]  K. Jellinger,et al.  Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.

[8]  D. German,et al.  Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex , 1987, Neuroscience.

[9]  H. Braak,et al.  Filamentous Tau Pathology in Nerve Cells, Astrocytes, and Oligodendrocytes of Aged Baboons , 2000, Journal of neuropathology and experimental neurology.

[10]  I. Grundke‐Iqbal,et al.  Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. , 2008, Current Alzheimer research.

[11]  Karl Herrup,et al.  Reimagining Alzheimer's Disease—An Age-Based Hypothesis , 2010, The Journal of Neuroscience.

[12]  J. Valk,et al.  MYELINATION AS AN EXPRESSION OF THE FUNCTIONAL MATURITY OF THE BRAIN , 1991, Developmental medicine and child neurology.

[13]  B. Reisberg,et al.  Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer’s and other dementing processes , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[14]  A. Korczyn The amyloid cascade hypothesis , 2008, Alzheimer's & Dementia.

[15]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[16]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[17]  G. Bartzokis Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[18]  H. Soininen,et al.  Hyperphosphorylated tau in young and middle-aged subjects , 2011, Acta Neuropathologica.

[19]  D. German,et al.  Axonal and transneuronal transport in the transmission of neurological disease: Potential role in system degenerations, including alzheimer's disease , 1987, Neuroscience.

[20]  Stefan Skare,et al.  See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication Extensive Blockinpiano Blockinpracticing Blockinhas Blockinregionally Specific Blockineffects Blockinon Blockinwhite Blockinmatter Blockindevelopment , 2022 .

[21]  Richard J. Kryscio,et al.  Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies , 2011, Acta Neuropathologica.

[22]  E. Mandelkow,et al.  Tau protein and tau aggregation inhibitors , 2010, Neuropharmacology.

[23]  V. Lee,et al.  Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles* , 2011, The Journal of Biological Chemistry.

[24]  S. Resnick,et al.  Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. , 2010, Brain : a journal of neurology.

[25]  D. Fergusson,et al.  Systematic Review of Measures of Clinical Significance Employed in Randomized Controlled Trials of Drugs for Dementia , 2009, Journal of the American Geriatrics Society.

[26]  Fredrik Ullén,et al.  Is activity regulation of late myelination a plastic mechanism in the human nervous system? , 2009, Neuron glia biology.

[27]  T. Ohm,et al.  Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology , 2004, Neurobiology of Aging.

[28]  Jay N Giedd,et al.  The teen brain: insights from neuroimaging. , 2008, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[29]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[30]  E. Mandelkow,et al.  Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease , 2007, Brain pathology.

[31]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[32]  Alan C. Evans,et al.  Maturation of white matter in the human brain: a review of magnetic resonance studies , 2001, Brain Research Bulletin.

[33]  Kazuhiko Yanai,et al.  18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. , 2011, Brain : a journal of neurology.

[34]  H. Braak,et al.  Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.

[35]  Charles D. Smith,et al.  Neuropathologic substrate of mild cognitive impairment. , 2006, Archives of neurology.

[36]  Peter T Nelson,et al.  Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity , 2007, Journal of neuropathology and experimental neurology.

[37]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[38]  Markus Tolnay,et al.  The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.

[39]  H. Braak,et al.  Poor and protracted myelination as a contributory factor to neurodegenerative disorders , 2004, Neurobiology of Aging.

[40]  B. Reisberg,et al.  Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD. , 2010, Current Alzheimer research.

[41]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[42]  K. A. Wollen,et al.  Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. , 2010, Alternative medicine review : a journal of clinical therapeutic.

[43]  Dietmar R. Thal,et al.  Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.

[44]  R. Pearson,et al.  Cortical connections and the pathology of Alzheimer's disease. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[45]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[46]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[47]  S. Pimplikar,et al.  Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.

[48]  C. Saper,et al.  Neurofibrillary tangles in the cerebral cortex of sheep , 1994, Neuroscience Letters.

[49]  D. Price,et al.  Neurofibrillary Tangles and Senile Plaques in Aged Bears , 1988, Journal of neuropathology and experimental neurology.

[50]  M. Diamond,et al.  Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.

[51]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[52]  M. Mesulam,et al.  Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum , 2004, Annals of neurology.